Comparison of the Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax and ProAir HFA in Pediatric Patients With Persistent Asthma
Phase of Trial: Phase I
Latest Information Update: 09 Nov 2015
At a glance
- Drugs Salbutamol (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- 01 Oct 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Sep 2013 Planned end date changed from 1 Sep 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 09 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.